Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2005-1-26
pubmed:abstractText
The cytochrome P450 2D6 (CYP2D6) enzyme metabolizes risperidone. CYP2D6 poor metabolizers have no CYP2D6 activity (7% of whites and 1%-2% of other races). This study tested whether the CYP2D6 poor metabolizer phenotype was associated with adverse drug reactions (ADRs) and discontinuation due to ADRs.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
0160-6689
pubmed:author
pubmed:issnType
Print
pubmed:volume
66
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
15-27
pubmed:dateRevised
2008-11-21
pubmed:meshHeading
pubmed-meshheading:15669884-Adult, pubmed-meshheading:15669884-Antipsychotic Agents, pubmed-meshheading:15669884-Basal Ganglia Diseases, pubmed-meshheading:15669884-Cytochrome P-450 CYP2D6, pubmed-meshheading:15669884-Dose-Response Relationship, Drug, pubmed-meshheading:15669884-Drug Therapy, Combination, pubmed-meshheading:15669884-Female, pubmed-meshheading:15669884-Genetic Variation, pubmed-meshheading:15669884-Genotype, pubmed-meshheading:15669884-Humans, pubmed-meshheading:15669884-Logistic Models, pubmed-meshheading:15669884-Male, pubmed-meshheading:15669884-Mental Disorders, pubmed-meshheading:15669884-Oligonucleotide Array Sequence Analysis, pubmed-meshheading:15669884-Patient Dropouts, pubmed-meshheading:15669884-Pharmacogenetics, pubmed-meshheading:15669884-Phenotype, pubmed-meshheading:15669884-Polymerase Chain Reaction, pubmed-meshheading:15669884-Risperidone, pubmed-meshheading:15669884-Schizophrenia
pubmed:year
2005
pubmed:articleTitle
The CYP2D6 poor metabolizer phenotype may be associated with risperidone adverse drug reactions and discontinuation.
pubmed:affiliation
University of Kentucky Mental Health Research Center at Eastern State Hospital, Lexington, KY 40508, USA. jdeleon@uky.edu
pubmed:publicationType
Journal Article, Comparative Study, Research Support, Non-U.S. Gov't